Micro Cap Growth Fund
Daily price w/o sales charge as of 02/13/2026
$19.77
$0.19
YTD Returns w/o sales charge as of 02/13/2026
1.44%
Please click here for performance current to the most recent quarter-end and month-end.
Summary
Summary
Fund Basicsas of 01/30/2026
- Total Net Assets
- $186.37 M
- Inception Date
- 05/01/2000
- Dividend Frequency
- Annually
- Fund Gross Expense Ratio
- 1.38%
- Fund Net Expense Ratio
- 1.38%
- Number of Holdings
- 77
- Minimum Initial Investment
- $1,500+
Fund Expense Ratio :
Gross 1.38%
Net 1.38%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | 1.80% | 12.41% | 11.69% | 0.55% | 16.55% | 10.33% |
| Lipper Category Avg. Small-Cap Growth Funds | 3.38% | 7.69% | 11.13% | 2.67% | 11.69% | - |
| Russell Microcap® Growth Index | 3.97% | 27.39% | 15.26% | 1.13% | 9.89% | - |
| w/ sales charge | -4.06% | 5.93% | 9.50% | -0.63% | 15.86% | 10.08% |
Fund Expense Ratio :
Gross 1.38%
Net 1.38%
Fund Expense Ratio :
Gross 1.38%
Net 1.38%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | 10.74% | 10.74% | 14.16% | 1.72% | 14.33% | 10.29% |
| Lipper Category Avg. Small-Cap Growth Funds | 8.15% | 8.15% | 13.21% | 2.52% | 10.17% | - |
| Russell Microcap® Growth Index | 21.84% | 21.84% | 17.46% | 2.81% | 7.82% | - |
| w/ sales charge | 4.39% | 4.39% | 11.93% | 0.52% | 13.66% | 10.04% |
Fund Expense Ratio :
Gross 1.38%
Net 1.38%
Returns with sales charges reflect a maximum sales charge of 5.75%.
Past performance is not a reliable indicator or guarantee of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost.
TEN LARGEST HOLDINGS as of 12/31/2025View Portfolio
| Holding | Assets |
|---|---|
| Cogent Biosciences Inc | 4.1% |
| Tarsus Pharmaceuticals Inc | 3.1% |
| Adaptive Biotechnologies Corp | 2.9% |
| Celcuity Inc | 2.7% |
| Terns Pharmaceuticals Inc | 2.6% |
| Artivion Inc | 2.4% |
| Willdan Group Inc | 2.3% |
| GeneDx Holdings Corp | 2.2% |
| Applied Digital Corp | 2.1% |
| Xometry Inc | 2.1% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 01/30/2026View Portfolio
| Sector | Weighting |
|---|
| Sector | Weighting |
|---|---|
| Communication Services | |
| Real Estate | |
| Utilities | |
| Consumer Discretionary | |
| Consumer Staples | |
| Energy | |
| Financials | |
| Health Care | |
| Industrials | |
| Information Technology | |
| Materials |
INVESTMENT TEAM
Your Representative
To contact your representative, enter your zip code and select your channel below.
Performance
Performance
Fund Expense Ratio :
Gross 1.38%
Net 1.38%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | 1.80% | 12.41% | 11.69% | 0.55% | 16.55% | 10.33% |
| Lipper Category Avg. Small-Cap Growth Funds | 3.38% | 7.69% | 11.13% | 2.67% | 11.69% | - |
| Russell Microcap® Growth Index | 3.97% | 27.39% | 15.26% | 1.13% | 9.89% | - |
| w/ sales charge | -4.06% | 5.93% | 9.50% | -0.63% | 15.86% | 10.08% |
Fund Expense Ratio :
Gross 1.38%
Net 1.38%
Fund Expense Ratio :
Gross 1.38%
Net 1.38%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 05/01/2000 |
|---|
| w/o sales charge | 10.74% | 10.74% | 14.16% | 1.72% | 14.33% | 10.29% |
| Lipper Category Avg. Small-Cap Growth Funds | 8.15% | 8.15% | 13.21% | 2.52% | 10.17% | - |
| Russell Microcap® Growth Index | 21.84% | 21.84% | 17.46% | 2.81% | 7.82% | - |
| w/ sales charge | 4.39% | 4.39% | 11.93% | 0.52% | 13.66% | 10.04% |
Fund Expense Ratio :
Gross 1.38%
Net 1.38%
Returns with sales charges reflect a maximum sales charge of 5.75%.
Past performance is not a reliable indicator or guarantee of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost.
| Year | Fund Returns | Russell Microcap® Growth Index |
|---|
| 2025 | 10.74% | 21.84% |
| 2024 | 26.89% | 21.91% |
| 2023 | 5.88% | 9.11% |
| 2022 | -29.27% | -29.76% |
| 2021 | 3.46% | 0.88% |
| 2020 | 79.42% | 40.13% |
| 2019 | 34.57% | 23.33% |
| 2018 | 2.74% | -14.18% |
| 2017 | 38.43% | 16.65% |
| 2016 | 2.07% | 6.86% |
| 2015 | -6.38% | - |
| 2014 | 10.83% | - |
| 2013 | 78.53% | - |
| 2012 | 2.35% | - |
| 2011 | -5.87% | - |
| 2010 | 33.77% | - |
| 2009 | 52.61% | - |
| 2008 | -46.45% | - |
| 2007 | 22.76% | - |
| 2006 | 25.37% | - |
| Year | Q1 | Q2 | Q3 | Q4 |
|---|
| 2026 | - | - | - | - |
| 2025 | -17.90% | 15.85% | 13.92% | 2.20% |
| 2024 | 7.64% | 0.07% | 6.89% | 10.21% |
| 2023 | 5.50% | 4.20% | -13.40% | 11.23% |
| 2022 | -17.22% | -22.57% | 8.17% | 2.02% |
| 2021 | 12.29% | -0.15% | -9.42% | 1.87% |
| 2020 | -24.28% | 47.61% | 17.48% | 36.65% |
| 2019 | 22.67% | 7.47% | -13.91% | 18.57% |
| 2018 | 5.24% | 15.77% | 10.08% | -23.39% |
| 2017 | 9.00% | 8.12% | 13.61% | 3.39% |
| 2016 | -13.70% | 6.01% | 14.49% | -2.55% |
| 2015 | 7.33% | 4.15% | -16.30% | 0.06% |
| 2014 | 7.92% | -6.53% | -6.55% | 17.58% |
| 2013 | 21.83% | 15.00% | 17.29% | 8.65% |
| 2012 | 17.67% | -9.76% | 1.32% | -4.87% |
| 2011 | 4.82% | 0.11% | -21.90% | 14.86% |
| 2010 | 6.60% | -8.74% | 15.08% | 19.49% |
| 2009 | -0.95% | 31.46% | 13.47% | 3.29% |
| 2008 | -23.22% | 4.46% | -5.93% | -29.02% |
| 2007 | 5.64% | 9.81% | 4.01% | 1.76% |
| 2006 | 17.15% | -9.83% | 1.22% | 17.25% |
| 2005 | -9.50% | 5.88% | 6.91% | 0.10% |
| 2004 | 12.33% | 1.65% | -11.11% | 24.03% |
| 2003 | -3.55% | 27.29% | 11.68% | 8.93% |
| 2002 | -0.18% | -12.74% | -21.79% | 1.33% |
| 2001 | 2.34% | 12.03% | -21.11% | 29.32% |
Performance is shown for each quarter and each calendar year. Past performance is no guarantee of future results.
Growth of $10,000 as of 01/31/2026
The chart begins on the Fund's inception date of 05/01/2000.
Based on a hypothetical Class A share investment of $10,000 on 05/01/2000 without sales charge and includes the reinvestment of all distributions.
NAV Historical Prices
| Date | Net Asset Value |
|---|
Portfolio
Portfolio
| Holding | Sector | Assets |
|---|
| Cogent Biosciences Inc | Health Care | 4.1% |
| Tarsus Pharmaceuticals Inc | Health Care | 3.1% |
| Adaptive Biotechnologies Corp | Health Care | 2.9% |
| Celcuity Inc | Health Care | 2.7% |
| Terns Pharmaceuticals Inc | Health Care | 2.6% |
| Artivion Inc | Health Care | 2.4% |
| Willdan Group Inc | Industrials | 2.3% |
| GeneDx Holdings Corp | Health Care | 2.2% |
| Applied Digital Corp | Information Technology | 2.1% |
| Xometry Inc | Industrials | 2.1% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
| Holding | Sector | Assets |
|---|
| Cogent Biosciences Inc | Health Care | 4.1% |
| Tarsus Pharmaceuticals Inc | Health Care | 3.1% |
| Adaptive Biotechnologies Corp | Health Care | 2.9% |
| Celcuity Inc | Health Care | 2.7% |
| Terns Pharmaceuticals Inc | Health Care | 2.6% |
| Artivion Inc | Health Care | 2.4% |
| Willdan Group Inc | Industrials | 2.3% |
| GeneDx Holdings Corp | Health Care | 2.2% |
| Applied Digital Corp | Information Technology | 2.1% |
| Xometry Inc | Industrials | 2.1% |
| Primoris Services Corp | Industrials | 2.1% |
| Mirum Pharmaceuticals Inc | Health Care | 2.1% |
| Beta Bionics Inc | Health Care | 2.0% |
| Centrus Energy Corp | Energy | 2.0% |
| Terawulf Inc | Information Technology | 1.9% |
| CECO Environmental Corp | Industrials | 1.8% |
| TAT Technologies Ltd | Industrials | 1.8% |
| PTC Therapeutics Inc | Health Care | 1.8% |
| Paymentus Holdings Inc | Financials | 1.8% |
| Rhythm Pharmaceuticals Inc | Health Care | 1.7% |
| Calix Inc | Information Technology | 1.7% |
| Vita Coco Co Inc/The | Consumer Staples | 1.7% |
| Mineralys Therapeutics Inc | Health Care | 1.7% |
| Agilysys Inc | Information Technology | 1.7% |
| Mercury Systems Inc | Industrials | 1.7% |
| OSI Systems Inc | Information Technology | 1.6% |
| Sterling Infrastructure Inc | Industrials | 1.6% |
| Bel Fuse Inc | Information Technology | 1.6% |
| VSE Corp | Industrials | 1.5% |
| Piper Sandler Cos | Financials | 1.5% |
| Cardinal Infrastructure Group Inc | Industrials | 1.4% |
| Praxis Precision Medicines Inc | Health Care | 1.4% |
| Huron Consulting Group Inc | Industrials | 1.4% |
| Pattern Group Inc | Consumer Discretionary | 1.3% |
| Arlo Technologies Inc | Information Technology | 1.3% |
| nLight Inc | Information Technology | 1.3% |
| Standex International Corp | Industrials | 1.3% |
| Dave Inc | Financials | 1.3% |
| Lindblad Expeditions Holdings Inc | Consumer Discretionary | 1.2% |
| Universal Technical Institute Inc | Consumer Discretionary | 1.1% |
| Miami International Holdings Inc | Financials | 1.1% |
| Legence Corp | Industrials | 1.1% |
| Arcellx Inc | Health Care | 1.0% |
| IMAX Corp | Communication Services | 1.0% |
| BlackSky Technology Inc | Industrials | 0.9% |
| TransMedics Group Inc | Health Care | 0.9% |
| Ouster Inc | Information Technology | 0.9% |
| HeartFlow Inc | Health Care | 0.9% |
| Red Violet Inc | Information Technology | 0.9% |
| Ambarella Inc | Information Technology | 0.8% |
| Sphere Entertainment Co | Communication Services | 0.8% |
| Lincoln Educational Services Corp | Consumer Discretionary | 0.8% |
| Travere Therapeutics Inc | Health Care | 0.8% |
| Kestra Medical Technologies Ltd | Health Care | 0.8% |
| Omada Health Inc | Health Care | 0.8% |
| Newamsterdam Pharma Co NV | Health Care | 0.8% |
| CG oncology Inc | Health Care | 0.8% |
| Genius Sports Ltd | Consumer Discretionary | 0.8% |
| Gilat Satellite Networks Ltd | Information Technology | 0.8% |
| ThredUp Inc | Consumer Discretionary | 0.7% |
| Powell Industries Inc | Industrials | 0.7% |
| ORIC Pharmaceuticals Inc | Health Care | 0.7% |
| Oddity Tech Ltd | Consumer Staples | 0.6% |
| Hinge Health Inc | Health Care | 0.6% |
| Billiontoone Inc | Health Care | 0.6% |
| Ceribell Inc | Health Care | 0.5% |
| Chefs' Warehouse Inc/The | Consumer Staples | 0.5% |
| Argan Inc | Industrials | 0.5% |
| Neptune Insurance Holdings Inc | Financials | 0.5% |
| D-Wave Quantum Inc | Information Technology | 0.5% |
| Grid Dynamics Holdings Inc | Information Technology | 0.5% |
| Black Rock Coffee Bar Inc | Consumer Discretionary | 0.3% |
| Innodata Inc | Industrials | 0.3% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 01/30/2026
| Sector | Weighting | Fund Change from Previous Quarter |
|---|
| Sector | Weighting | Fund Change from Previous Quarter |
|---|---|---|
| Communication Services |
0.2%
|
|
| Real Estate | 0.0% | |
| Utilities | 0.0% | |
| Consumer Discretionary |
0.3%
|
|
| Consumer Staples |
 0.1%
|
|
| Energy |
0.3%
|
|
| Financials |
0.9%
|
|
| Health Care |
4.0%
|
|
| Industrials |
3.5%
|
|
| Information Technology |
0.5%
|
|
| Materials | 0.0% |
Portfolio Details as of 01/30/2026
- Total Net Assets
- $186.37 M
- Number of Holdings
- 77
- Weighted Average Market Cap.
- 3.6 B
- P/B Ratio
- 6.8x
- P/E Ratio
- 33.6x
To view definitions for the above Portfolio Details, Click here.
P/B Ratio - A ratio that helps determine whether a stock is undervalued or overvalued. It is calculated by dividing a stock's price per share by its book value per share. The result is based upon a weighted average of the securities held in the fund.
P/E Ratio - Is the weighted average of each holding's P/E ratio (price of a stock divided by its earnings per share). The result is based upon a weighted average of the securities held in the fund.
Weighted Average Market Cap - The average market capitalization of all companies held in the portfolio with each company weighted according to its percent held in the portfolio. The result is based upon a weighted average of the securities held in the fund.
Dividends & Cap Gains
Dividends & Cap Gains
Dividend Payments
- YTD Dividends Paidas of 02/13/2026
- $0
- Dividend Frequency
- Annually
| Record Date | Ex-Dividend Date | Reinvest & Payable Date | Dividend | Reinvest Price |
|---|---|---|---|---|
| 11/20/2001 | 11/21/2001 | 11/21/2001 | $0.00740 | $10.09 |
Upcoming Dividend Payment Dates
This section lists all anticipated Income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.
| Record Date | Ex-Dividend Date | Reinvest & Payable Date |
|---|---|---|
| 11/23/2026 | 11/24/2026 | 11/24/2026 |
Capital Gains Distributions
| Record Date | Reinvest & Payable Date | Long-term | Short-term * | Total | Reinvest Price |
|---|---|---|---|---|---|
| 11/23/2020 | 11/24/2020 | $2.8043 | $2.2741 | $5.0784 | $15.43 |
Taxed as ordinary income
Lord Abbett does not provide tax advice. It is strongly recommended that you discuss the impact of dividends and distributions with your tax advisor.
Fees & Expenses
Fees & Expenses
Sales Charge Schedule as of 02/13/2026
| Sales Charge | Dealer's Concession | Prices at Breakpoint | |
|---|---|---|---|
| Less than $50,000 | 5.75% | 5.00% | $20.98 |
| $50,000 to $99,999 | 4.75% | 4.00% | $20.76 |
| $100,000 to $249,999 | 3.95% | 3.25% | $20.58 |
| $250,000 to $499,999 | 2.75% | 2.25% | $20.33 |
| $500,000 to $999,999 | 1.95% | 1.75% | $20.16 |
| $1,000,000 to $5,000,000 | 0.00% | 1.00% | $19.77 |
The 12b-1 trail commission is 0.15% (accrues immediately) for all fixed-income and municipal income funds.
Class A shares purchased without a sales charge (commissionable NAV) will be subject to a CDSC of 1% if they are redeemed before the first day of the month in which the one-year anniversary of the purchase falls.
Expense Ratioas of 01/31/2026
| Fund Gross Expense Ratio | 1.38% |
| Fund Net Expense Ratio | 1.38% |
Fund Documents
Fund Documents
|
0Documents selected
|
||||
|---|---|---|---|---|
|
Portfolio Holdings 1Q
Publish Date:11/03/2015
|
||||
|
Portfolio Holdings 3Q
Publish Date:11/03/2015
|
||||
|
Summary Prospectus
Publish Date:11/03/2015
|
||||
|
Statutory Prospectus
Publish Date:11/03/2015
|
||||
|
SAI
Publish Date:11/03/2015
|
||||
|
Annual Financial Statements and Other Information *
Publish Date:11/03/2015
|
||||
|
2025 Annual Tailored Shareholder Report
Publish Date:11/03/2015
|
||||
|
2025 Semi-Annual Tailored Shareholder Report
Publish Date:11/03/2015
|
||||
|
Semi-Annual Financial Statements and Other Information *
Publish Date:11/03/2015
|
||||
|
Fact Sheet
Publish Date:11/03/2015
|